Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriam Labopin

Showing results (341-350 of 443) with videos related to

Pageof 45
Sort By:
Bone Marrow Transplantation|November 9, 2021
Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemiaChristoph Schmid, Myriam Labopin, Nicolaas Schaap, et al.
Leukemia|May 13, 2020
Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemiaArnon Nagler, Bhagirathbhai Dholaria, Myriam Labopin, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 10, 2021
Predictive Factors for Outcome of First Allogeneic Transplant for Elderly Patients With Acute Lymphoblastic LeukemiaAbdul Hamid Bazarbachi, Myriam Labopin, Nicolaus Kröger, et al.
Cancer Medicine|January 20, 2022
Measurable residual disease, FLT3-ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1-mutated acute myeloid leukemiaRama Al Hamed, Myriam Labopin, Etienne Daguindau, et al.
Bone Marrow Transplantation|July 30, 2020
Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: a survey on behalf of the ALWP of the EBMTArnon Nagler, Frédéric Baron, Myriam Labopin, et al.
European Journal of Haematology|June 2, 2012
Mobilized peripheral blood stem cells compared with bone marrow from HLA-identical siblings for reduced-intensity conditioning transplantation in acute myeloid leukemia in complete remission: a retrospective analysis from the Acute Leukemia Working Party of EBMTArnon Nagler, Myriam Labopin, Avichai Shimoni, et al.
Journal of Crohn'S & Colitis|May 23, 2018
Autologous Haematopoietic Stem Cell Transplantation for Crohn's Disease: A Retrospective Survey of Long-term Outcomes From the European Society for Blood and Marrow TransplantationCharlotte K Brierley, Cristina Castilla-Llorente, Myriam Labopin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 23, 2014
Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Malignancies Working PartyMarie Robin, Annalisa Ruggeri, Myriam Labopin, et al.
Bone Marrow Transplantation|May 2, 2022
Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemiaArnon Nagler, Christophe Peczynski, Bhagirathbhai Dholaria, et al.
JACC. Cardiooncology|August 16, 2021
Early Cardiac Toxicity Associated With Post-Transplant Cyclophosphamide in Allogeneic Stem Cell TransplantationRémy Duléry, Razan Mohty, Myriam Labopin, et al.
Pageof 45

Showing results (341-350 of 443) with videos related to

Sort By:
Pageof 45
Bone Marrow Transplantation|November 9, 2021
Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemiaChristoph Schmid, Myriam Labopin, Nicolaas Schaap, et al.
Leukemia|May 13, 2020
Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemiaArnon Nagler, Bhagirathbhai Dholaria, Myriam Labopin, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 10, 2021
Predictive Factors for Outcome of First Allogeneic Transplant for Elderly Patients With Acute Lymphoblastic LeukemiaAbdul Hamid Bazarbachi, Myriam Labopin, Nicolaus Kröger, et al.
Cancer Medicine|January 20, 2022
Measurable residual disease, FLT3-ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1-mutated acute myeloid leukemiaRama Al Hamed, Myriam Labopin, Etienne Daguindau, et al.
Bone Marrow Transplantation|July 30, 2020
Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: a survey on behalf of the ALWP of the EBMTArnon Nagler, Frédéric Baron, Myriam Labopin, et al.
European Journal of Haematology|June 2, 2012
Mobilized peripheral blood stem cells compared with bone marrow from HLA-identical siblings for reduced-intensity conditioning transplantation in acute myeloid leukemia in complete remission: a retrospective analysis from the Acute Leukemia Working Party of EBMTArnon Nagler, Myriam Labopin, Avichai Shimoni, et al.
Journal of Crohn'S & Colitis|May 23, 2018
Autologous Haematopoietic Stem Cell Transplantation for Crohn's Disease: A Retrospective Survey of Long-term Outcomes From the European Society for Blood and Marrow TransplantationCharlotte K Brierley, Cristina Castilla-Llorente, Myriam Labopin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 23, 2014
Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Malignancies Working PartyMarie Robin, Annalisa Ruggeri, Myriam Labopin, et al.
Bone Marrow Transplantation|May 2, 2022
Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemiaArnon Nagler, Christophe Peczynski, Bhagirathbhai Dholaria, et al.
JACC. Cardiooncology|August 16, 2021
Early Cardiac Toxicity Associated With Post-Transplant Cyclophosphamide in Allogeneic Stem Cell TransplantationRémy Duléry, Razan Mohty, Myriam Labopin, et al.
Pageof 45